Cantor Fitzgerald Analysts Give Viewray (VRAY) a $13.00 Price Target

Cantor Fitzgerald set a $13.00 target price on Viewray (NASDAQ:VRAY) in a research note released on Monday, January 8th. The brokerage currently has a buy rating on the stock. Cantor Fitzgerald also issued estimates for Viewray’s FY2017 earnings at ($1.03) EPS and FY2018 earnings at ($0.59) EPS.

Other equities research analysts have also issued research reports about the stock. ValuEngine lowered shares of Viewray from a hold rating to a sell rating in a research note on Friday, September 22nd. Mizuho reiterated a buy rating and issued a $12.00 price objective on shares of Viewray in a report on Tuesday, September 26th. Northland Securities reiterated a buy rating and issued a $10.00 price objective on shares of Viewray in a report on Friday, November 17th. Finally, BidaskClub cut shares of Viewray from a buy rating to a hold rating in a report on Saturday, December 9th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the company’s stock. Viewray presently has an average rating of Buy and a consensus price target of $11.20.

Viewray (NASDAQ VRAY) traded down $0.04 during trading hours on Monday, reaching $8.89. 37,778 shares of the company’s stock were exchanged, compared to its average volume of 777,022. The stock has a market cap of $627.48, a PE ratio of -7.90 and a beta of 0.13. The company has a current ratio of 1.59, a quick ratio of 1.20 and a debt-to-equity ratio of -1.67. Viewray has a one year low of $4.40 and a one year high of $10.64.

Viewray (NASDAQ:VRAY) last issued its earnings results on Monday, November 13th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.07). The firm had revenue of $12.20 million for the quarter, compared to analyst estimates of $18.63 million. The company’s revenue for the quarter was up 2950.0% on a year-over-year basis. analysts predict that Viewray will post -1.05 earnings per share for the current year.

A number of hedge funds have recently added to or reduced their stakes in VRAY. Nationwide Fund Advisors lifted its position in Viewray by 843.2% in the 2nd quarter. Nationwide Fund Advisors now owns 16,543 shares of the company’s stock worth $107,000 after buying an additional 14,789 shares in the last quarter. HighTower Advisors LLC raised its holdings in shares of Viewray by 5.0% during the 2nd quarter. HighTower Advisors LLC now owns 21,000 shares of the company’s stock valued at $135,000 after purchasing an additional 1,000 shares in the last quarter. The Manufacturers Life Insurance Company bought a new position in shares of Viewray during the 2nd quarter valued at $159,000. Thompson Siegel & Walmsley LLC bought a new position in shares of Viewray during the 3rd quarter valued at $164,000. Finally, White Pine Capital LLC acquired a new position in Viewray in the 2nd quarter valued at $173,000. Institutional investors own 50.52% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Cantor Fitzgerald Analysts Give Viewray (VRAY) a $13.00 Price Target” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/01/viewray-vray-given-a-13-00-price-target-at-cantor-fitzgerald.html.

About Viewray

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

Analyst Recommendations for Viewray (NASDAQ:VRAY)

Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply